Daiichi Sankyo Co Ltd
TSE:4568
Daiichi Sankyo Co Ltd
Income from Continuing Operations
Daiichi Sankyo Co Ltd
Income from Continuing Operations Peer Comparison
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Daiichi Sankyo Co Ltd
TSE:4568
|
Income from Continuing Operations
¥201B
|
CAGR 3-Years
39%
|
CAGR 5-Years
16%
|
CAGR 10-Years
12%
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Income from Continuing Operations
¥144.2B
|
CAGR 3-Years
-27%
|
CAGR 5-Years
1%
|
CAGR 10-Years
3%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Income from Continuing Operations
¥141.7B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
11%
|
CAGR 10-Years
-1%
|
|
S
|
Shionogi & Co Ltd
TSE:4507
|
Income from Continuing Operations
¥160.6B
|
CAGR 3-Years
13%
|
CAGR 5-Years
3%
|
CAGR 10-Years
15%
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Income from Continuing Operations
¥326.4B
|
CAGR 3-Years
16%
|
CAGR 5-Years
27%
|
CAGR 10-Years
18%
|
|
Astellas Pharma Inc
TSE:4503
|
Income from Continuing Operations
¥17B
|
CAGR 3-Years
-48%
|
CAGR 5-Years
-40%
|
CAGR 10-Years
-15%
|
See Also
What is Daiichi Sankyo Co Ltd's Income from Continuing Operations?
Income from Continuing Operations
201B
JPY
Based on the financial report for Mar 31, 2024, Daiichi Sankyo Co Ltd's Income from Continuing Operations amounts to 201B JPY.
What is Daiichi Sankyo Co Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
12%
Over the last year, the Income from Continuing Operations growth was 85%. The average annual Income from Continuing Operations growth rates for Daiichi Sankyo Co Ltd have been 39% over the past three years , 16% over the past five years , and 12% over the past ten years .